Clinical trials in Kazanlak – page 2

Innovative clinical trials focusing on schizophrenia treatment, testing new adjunctive therapies to help patients with inadequately controlled symptoms. Multiple studies are evaluating novel compounds to enhance the effectiveness of existing treatments.

• Treatment-resistant schizophrenia
• Adjunctive therapy development
• Long-term safety assessment

Research aims to improve quality of life for patients with persistent symptoms.

Groundbreaking research into bipolar I disorder, specifically focusing on manic episodes and mixed features. Studies are evaluating new therapeutic approaches for acute treatment of mania.

• Bipolar mania management
• Mixed episode treatment
• Acute intervention strategies

Trials aim to establish effective interventions for acute manic episodes.

Advanced clinical investigations targeting Major Depressive Disorder with innovative approaches. Studies are exploring genetic factors and new pharmaceutical interventions for improving depressive symptoms.

• Targeted therapy development
• Genetic profile assessment
• Symptom improvement evaluation

Research focuses on personalized treatment approaches based on genetic markers.